Anti-CD19 [CAT-13.1E10]

Absolute Antibody

Anti-CD19 [CAT-13.1E10]

7

This antibody is recommended for targeting and analysis of B cells. CAT-13.1E10 was used as a part of a fusion molecule aimed at intracellular delivery of BINDI in order to establish a potential treatment method of EBV-positive B lymphoma in a xenograft mouse model (US20160376333A1).

therapeutics

Research Use Only

Monoclonal

CAT-13.1E10

CD19

CD19 molecule

B4, CVID3, B-lymphocyte antigen CD19, B-lymphocyte surface antigen B4, T-cell surface antigen Leu-12, differentiation antigen CD19

Human

IgG1

B-lymphocyte antigen CD19

This chimeric human antibody was made using the variable domain sequences of the original Mouse IgG1 format, for improved compatibility with existing reagents, assays and techniques.

Human

Human

This antibody was raised by immunising mice against CD19.

-20°C,2°C to 8°C

41116161